Leelyn Smith’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-714	Closed	-$14.5K	–	171
2022 Q4	$14.5K	Buy	714 +357	+100%	+$7.27K	﹤0.01%	289
2022 Q3	$23K	Hold	357	–	–	0.01%	214
2022 Q2	$22K	Buy	+357	New	+$22K	0.01%	241